Demographic and clinical profile of black patients with chronic kidney disease attending Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) in Johannesburg, South Africa.

Background The prevalence of chronic kidney disease (CKD) is increasing worldwide; black patients have an increased risk of developing CKD and end stage kidney disease (ESKD) at significantly higher rates than other races. Methods A cross sectional study was carried out on black patients with CKD attending the kidney outpatient clinic at Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) in South Africa, between September 2019 to March 2020. Demographic and clinical data were extracted from the ongoing kidney outpatient clinic records and interviews, and were filled in a questionnaire. Patients provided blood and urine for laboratory investigations as standard of care, data were descriptively and inferentially analysed using STATA version 17. Multivariable logistic regression analysis was used to identify demographic and clinical data associated with advanced CKD. Results A total of 312 black patients with CKD were enrolled during the study period; 58% patients had advanced CKD, of whom 31.5% had grossly increased proteinuria, 96.7% had hypertension, 38.7% had diabetes mellitus and 38.1% had both hypertension and diabetes mellitus. For patients with advanced CKD, the median age was 61 (IQR 51-69) years, eGFR 33 (30 -39) mL/min/1.73 m2, serum bicarbonate 22 (IQR 20 - 24), hemoglobin 12.9 (IQR 11.5 - 14.0) g/dl, serum transferrin 2.44 (IQR 2.23 - 2.73) g/L, serum uric acid 0.43 (IQR 0.37 - 0.53) and serum potassium 4.4 (IQR 3.9 - 4.8) mmol/L. The prevalence of metabolic acidosis was 62.4%, anemia 46.4%, gout 30.9%, low transferrin levels 16.6% and hyperkalemia 8.8% among those with advanced CKD, while the prevalence of metabolic acidosis and anemia was 46.6% and 25.9% respectively in those with early CKD. Variables with higher odds for advanced CKD after multivariable logistic regression analysis were hypertension (OR 3.3, 95% CI 1.2 - 9.2, P = 0.020), diabetes mellitus (OR 1.8, 95% CI 1.1 - 3.3, P = 0.024), severe proteinuria (OR 3.5, 95% CI 1.9 - 6.5, P = 0.001), angina (OR 2.5, 95% CI 1.2 - 5.1, P = 0.008), anaemia (OR 2.9, 95% CI 1.7 - 4.9, P= 0.001), hyperuricemia (OR 2.4, 95% CI 1.4 - 4.1, P = 0.001), and metabolic acidosis (OR 2.0, 95% CI 1.2 - 3.1, P= 0.005). Other associations with advanced CKD were widow/widower (OR 3.2, 95% CI 1.4 - 7.4, P = 0.006), low transferrin (OR 2.4, 95% CI 1.1 - 5.1, P= 0.028), hyperkalemia (OR 5.4, 95% CI 1.2 - 24.1, P= 0.029), allopurinol (OR 2.4, 95% CI 1.4 - 4.3, P = 0.005) and doxazosin (OR 1.9, 95% CI 1.2 - 3.1, P = 0.006). Conclusion Hypertension and diabetes mellitus were strongly associated with advanced CKD, suggesting a need for primary and secondary population-based prevention measures. Metabolic acidosis, anaemia with low transferrin levels, hyperuricemia and hyperkalemia were highly prevalent in our patients, including those with early CKD, and they were strongly associated with advanced CKD, calling for the proactive role of clinicians and dietitians in supporting the needs of CKD patients in meeting their daily dietary requirements towards preventing and slowing the progression of CKD.

Introduction mellitus (HbA1C < 7%), attending the KOPD clinic for at least 6 months and were able to provide informed consent. Patients who had active infections, active malignancies, autoimmune diseases and who were not black were excluded. Johannesburg is the largest city in South Africa and among the largest 50 urban agglomerations in the world. Johannesburg had an estimated population of 5.9 million in 2021 with the most common racial groups being black African (76.4%), colored (5.6%), White (12.3%) and Indian/Asian (4.9%). The illiterate account for 7% of the population and 3.4% has only primary school education, and 29% of residents live in informal dwellings. Due to increased urbanization, there has been increased use of westernized dietary patterns often comprising of fast and deep-fried foods, processed meats, saturated fats, sugar sweetened beverages, alcoholic beverages plus other highly processed foods, unlike in rural areas where the traditional dietary patterns are predominant (29). Data collection and laboratory procedures Demographic and clinical data including age, gender, weight, height, glycemic status, history of smoking, etiology of CKD and medications were extracted from the ongoing continuous KOPD clinic records and face to face interviews, and were filled in a questionnaire. Systolic and diastolic blood pressure was measured 3 times, the average of the second and third measurements was used. Body mass index (BMI) was calculated using the National Health Services (NHS-UK) BMI calculator (30). Measurements of urinary protein creatinine ratio (uPCR), serum creatinine, electrolytes, HbA1C, WBC, haemoglobin level, platelets, calcium, phosphate, transferrin and HDL cholesterol were done as standard of care at the time of recruitment during a clinic visit. Serum creatinine was measured using the isotope dilution mass spectrometry (IDMS) traceable enzymatic assay and estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation without using the African American correction factor (31). Patients with eGFR < 45 ml/min/1.72m 2 were considered to have advanced CKD, while those patients with eGFR ≥ 45 ml/min/1.72m 2 early CKD. Data management and analysis Data collected was entered into a REDCap (Research Electronic Data Capture) (Vanderbilt University, 2014) database and analyzed using STATA version 17 (College Station, Texas, USA). Descriptive statistics were used to summarize demographic and clinical characteristics; continuous variables have been reported as medians with interquartile ranges and Wilcoxon rank-sum test was used for the non-normally distributed variables. Discrete variables have been reported as frequencies and proportions, Pearson's chi-square test were used to test for association between two variables. Odd ratios were used to estimate the strengths of association between variables and advanced CKD, univariate and multivariate logistic regression models have been used to estimate the association of variables and advanced CKD. Variables with p-value less than 0.2 on univariate logistic regression models were then fitted into the multivariate logistic regression models with the addition of age and sex as adjusting variables; variables with a p-value of less than 0.05 were considered to have significant strength of association.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 16, 2022.

Ethical issues
Ethical approval was obtained from the Human Research Ethics Committee of the University of Witwatersrand, Johannesburg (ethics clearance certificate No. M190553). Informed consent was obtained from each of the participants before embarking on data collection.

(which was not certified by peer review)
The copyright holder for this preprint this version posted March 16, 2022. ; Clinical profile of CKD patients Of the 312 CKD black patients, 58% patients had advanced CKD (CKD stage 3b or 4), of whom 57 (31.5 %) patients presented with severely increased proteinuria as compared to 23  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted March 16, 2022   0.005 0.495 P < 0.05 was used to identify potential variables, those with P <0.2 in univariate were included into the multivariate analysis while adjusting for age and sex.

Discussion
This study evaluated the demographic and clinical profile of black patients with CKD attending the CMJAH kidney outpatient clinic in Johannesburg, South Africa. There were 42% with early CKD and 58% with advanced CKD, of whom 93.6% had hypertension and 33.0 % diabetes mellitus, and 32.3% had both hypertension and diabetes. The majority (96.7 %) of patients with advanced CKD had hypertension, similar to findings in other studies from SSA (9,10,32,33). Approximately 51.4 % of patients with advanced CKD were using doxazosin for treatment of hypertension with a 1.9 times increased association with advanced CKD, as also been reported in other studies (34,35). Peripherally acting α-blockers like doxazosin are commonly used in the management of hypertension in CKD, mainly due to their pharmacokinetic profile that is undisturbed by worsening kidney function and their role in blood sugar control (36). Approximately 38.7 % patients with advanced CKD had T2DM; T2DM had 1.8 increased risk for advanced CKD, similar to other studies conducted among black patients in South Africa, Tanzania and Ethiopia (1,9,33,37). In patients with advanced CKD, approximately 29.3 % of the patients were on insulin and 8.8 % were on oral hypoglycemics for treatment of their T2DM. Oral hypoglycemics were associated with 0.5 times higher risk for advanced CKD, similar to other studies (38,39). The prevalence of metabolic acidosis was 62.4 % in advanced CKD and 46.6 % in early CKD; this prevalence is higher than the 33% -40% among patients with CKD stage 3 -4 from other continents (14,40,41). The possible explanation could be firstly, the more rapid CKD progression which has been shown to occur in black patients even early in their CKD stages (16,28) and secondly, diet where replacement of traditional diets with contemporary/ western foods which contain mainly animal proteins, less vegetables and low intake of fruits might increase CKD patients' dietary acid load (29,(42)(43)(44)(45). Patients with low serum bicarbonate levels were 2-fold more likely to have advanced CKD, as reported also in other studies (14,15). The prevalence of anaemia was 46.4 % in advanced CKD, including 16.6 % who had low transferrin levels, while 25.9 % of the patients with early CKD had anemia. Advanced CKD was 2.9 times more prevalent if a patient had anemia and 2.4 times more prevalent if a patient had low transferrin, similar to other studies (17)(18)(19). The prevalence of hyperuricemia was 30.9 % in advanced CKD; advanced CKD had a 2.4-fold higher OR if a patient had hyperuricemia and 2.4-fold higher if a patient was on allopurinol; similar findings have been reported in other studies (11) (20)(21)(22). Approximately 8.8 % patients with advanced CKD were found to have hyperkalemia; hyperkalemia had a 5.4-. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted March 16, 2022. ; fold increased association with advanced CKD; similar findings have been reported in other studies (23,24). Studies have shown that the incidence of cardiovascular events increases with worsening kidney function (46,47); 22.7% patients with advanced CKD reported angina with a 2.5 times increased risk in advanced CKD, similar to other studies (46,48). Also 31.5 % patients with advanced CKD presented with severely increased proteinuria; advanced CKD was 3.5 times higher if a patient had severe proteinuria, as also reported in other studies (3,13,37,49). Furthermore, few (18.8 %) patients with advanced CKD and 21.4 % of those with early CKD were using ACEIs or ARBs; similar findings have been reported from other studies on the underutilization of ACEIs/ARBs when they were clinically indicated or discontinuation of RAAS inhibitors by clinicians during the course of CKD possibly due to their associated side effects (50)(51)(52). Angiotensin converting enzyme inhibitors (ACEIs) or angiotensin receptors blockers (ARBs) had no significant association with advanced CKD, possibly due to the small numbers on these agents, unlike findings from other studies that did demonstrate that the use of ACEIs/ARBs had beneficial effects for kidney events and cardiovascular outcomes compared to other antihypertensive medications in patients with CKD (52)(53)(54). The possible explanation could be the fact that the majority (84.0 %) of the study patients with advanced CKD were using calcium channel blockers. Studies have demonstrated that calcium channel blockers have similar kidney and cardiovascular protective effects when compared to RAAS blockers in patients with CKD (55,56).

Conclusion:
Hypertension and diabetes mellitus were strongly associated with advanced CKD, suggesting a need for primary and secondary population-based prevention measures. Metabolic acidosis, anemia with low transferrin levels, hyperuricemia and hyperkalemia were highly prevalent in our patients, including those with early CKD, and they were strongly associated with advanced CKD. This calls for the proactive role of clinicians and dietitians in supporting the needs of CKD patients in meeting their daily dietary requirements towards preventing and slowing the progression of CKD. Further studies on the role of diet including plant-based proteins, vegetables and fruits in preventing and slowing CKD progression and other metabolic complications of CKD among black patients are warranted. Abbreviations CKD, chronic kidney diseases; CMJAH, Charlotte Maxeke Johannesburg Academic Hospital; CKD-EPI, chronic kidney disease epidemiology collaboration; ESKD, end stage kidney disease; T2DM, Type 2 Diabetes Mellitus; eGFR, estimated glomerular filtration rate; IDMS, isotope dilution mass spectroscopy; uPCR, urine protein creatinine ratio; CCBs, calcium channel blockers; ACEIs, angiotensin converting enzyme inhibitors; ARBs, Aldosterone receptors blockers; KDIGO, kidney disease improving global outcomes; NCDs, non-communicable diseases; SSA, sub Saharan Africa Acknowledgements Special thanks to all patients with CKD attending at the Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) kidney outpatient clinic for their willingness to participate in this study and to . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 16, 2022. ; the staff at the Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) kidney outpatient clinic and laboratory for their continued care, proper keeping of patient data and support which made this study possible. I thank the International Society of Nephrology (ISN), the University of the Witwatersrand, the University of Dodoma and Shinei industries (Aichi, Japan) Co. Ltd, for support, and providing a good and conducive environment for my nephrology fellowship training.